Literature DB >> 24712323

Prevalence and clinical relevance of the morphological substrate of ventricular arrhythmias in patients without known cardiac conditions detected by cardiovascular MR.

J Weisser-Thomas1, V A Ferrari, A Lakghomi, L M Lickfett, G Nickenig, H H Schild, D Thomas.   

Abstract

OBJECTIVE: Cardiac MR (CMR) identifies the substrate of ventricular arrhythmia (VA) in cardiomyopathies and coronary heart disease. However, little is known about the value of CMR in patients with VA without previously known cardiac disorders.
METHODS: 76 patients with VA (Lown ≥2) without known cardiac disease after regular diagnostic work-up were studied with CMR, and findings were correlated with electrocardiogram (ECG) and electrophysiological stimulation (EPS). Structural abnormalities matching the VA origin as defined by ECG and/or EPS, or a CMR-detected cardiac condition known to cause arrhythmia were defined as VA substrate. CMR findings were defined as clinically relevant, if resulting in a new diagnosis, change of treatment or additional diagnostic procedure.
RESULTS: 44/76 patients demonstrated pathological CMR findings. In 24/76 patients, the pathology was detected by CMR and not by echocardiography. CMR-based diagnoses of cardiac disease were established in 20/76 patients, and all were morphological substrates for VA. In seven patients, the location of the CMR finding (scar) directly matched the VA origin. CMR findings resulted in a change of treatment in 21 patients and/or additional diagnostics in 8 patients.
CONCLUSION: Undetected cardiac conditions are frequent causes of VA. This is the first study demonstrating the value of CMR for detection of morphological substrate and/or underlying cardiac disorders in VA patients without known cardiac disease. ADVANCES IN KNOWLEDGE: The high incidence of clinically relevant CMR findings which were not detected during initial diagnostic work-up strongly supports the use of CMR to screen VA patients for underlying heart disease.

Entities:  

Mesh:

Year:  2014        PMID: 24712323      PMCID: PMC4075562          DOI: 10.1259/bjr.20140059

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  31 in total

1.  Myocarditis and arrhythmia: a clinico-pathological study of conduction system based on serial section in 65 cases.

Authors:  S Inoue; F Shinohara; T Sakai; H Niitani; T Saito; J Hiromoto; T Otsuka
Journal:  Jpn Circ J       Date:  1989-01

2.  Infarct morphology identifies patients with substrate for sustained ventricular tachycardia.

Authors:  David Bello; David S Fieno; Raymond J Kim; F Scott Pereles; Rod Passman; Gina Song; Alan H Kadish; Jeffrey J Goldberger
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

3.  Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches.

Authors:  Hassan Abdel-Aty; Philipp Boyé; Anja Zagrosek; Ralf Wassmuth; Andreas Kumar; Daniel Messroghli; Petra Bock; Rainer Dietz; Matthias G Friedrich; Jeanette Schulz-Menger
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

4.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study.

Authors:  Anja Wagner; Heiko Mahrholdt; Thomas A Holly; Michael D Elliott; Matthias Regenfus; Michele Parker; Francis J Klocke; Robert O Bonow; Raymond J Kim; Robert M Judd
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

5.  Results of biventricular endomyocardial biopsy in survivors of cardiac arrest with apparently normal hearts.

Authors:  A Frustaci; F Bellocci; E G Olsen
Journal:  Am J Cardiol       Date:  1994-11-01       Impact factor: 2.778

6.  Lymphocytic myocarditis presenting as unexplained ventricular arrhythmias: diagnosis with endomyocardial biopsy and response to immunosuppression.

Authors:  P A Vignola; K Aonuma; P S Swaye; J J Rozanski; R L Blankstein; J Benson; A J Gosselin; J W Lister
Journal:  J Am Coll Cardiol       Date:  1984-10       Impact factor: 24.094

7.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

Authors:  James C C Moon; William J McKenna; Jane A McCrohon; Perry M Elliott; Gillian C Smith; Dudley J Pennell
Journal:  J Am Coll Cardiol       Date:  2003-05-07       Impact factor: 24.094

8.  Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology.

Authors:  Heiko Mahrholdt; Christine Goedecke; Anja Wagner; Gabriel Meinhardt; Anasthasios Athanasiadis; Holger Vogelsberg; Peter Fritz; Karin Klingel; Reinhard Kandolf; Udo Sechtem
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

9.  Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.

Authors:  J A McCrohon; J C C Moon; S K Prasad; W J McKenna; C H Lorenz; A J S Coats; D J Pennell
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

10.  Cardiac histologic findings in patients with life-threatening ventricular arrhythmias of unknown origin.

Authors:  D D Sugrue; D R Holmes; B J Gersh; W D Edwards; C J McLaran; D L Wood; M J Osborn; S C Hammill
Journal:  J Am Coll Cardiol       Date:  1984-11       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.